Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP51087.RAarrsen-DqyQEczgLzWI5CiDh95NvKZx5lBKoJ7X0JLI130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51087.RAarrsen-DqyQEczgLzWI5CiDh95NvKZx5lBKoJ7X0JLI130_provenance.
• NP235103.RAxmx3r04DDe-RhggEDlKxuMDUZhYcWwkd8RMzhHfeHCg130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235103.RAxmx3r04DDe-RhggEDlKxuMDUZhYcWwkd8RMzhHfeHCg130_provenance.
• NP345270.RAAAe7tXkRchw7A5_lu-5OJF91b4Z8Z7PfTjBKAmR81Ww130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345270.RAAAe7tXkRchw7A5_lu-5OJF91b4Z8Z7PfTjBKAmR81Ww130_provenance.
• NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_provenance.
• NP345272.RAD3i_NKDV362I45wvOGp4fmVX3Pya0nHo-1EI8p3_wnY130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345272.RAD3i_NKDV362I45wvOGp4fmVX3Pya0nHo-1EI8p3_wnY130_provenance.
• NP345275.RABsuJlGXNxM0luyLHK6Phhvyt7ue7KhomusATN8_38ug130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345275.RABsuJlGXNxM0luyLHK6Phhvyt7ue7KhomusATN8_38ug130_provenance.
• NP345277.RA4F9D3xc4wihrLsxw7feAyGrhsot5YUORgRG4tzKYyKI130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345277.RA4F9D3xc4wihrLsxw7feAyGrhsot5YUORgRG4tzKYyKI130_provenance.
• NP979127.RA9YCbIQdUMikfzaeV0TCUQa0JkRPIWjJWddMIRdVRuXY130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979127.RA9YCbIQdUMikfzaeV0TCUQa0JkRPIWjJWddMIRdVRuXY130_provenance.
• NP979141.RA6g1H4TnEEAroJnwbnJiSxYi-W8DSz4Fb2ndLqSXBf5s130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979141.RA6g1H4TnEEAroJnwbnJiSxYi-W8DSz4Fb2ndLqSXBf5s130_provenance.
• NP345276.RAVU7ll3s8CFk1T1PM-ncURvqYn7ZYqtBN06fDk9JCA-s130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345276.RAVU7ll3s8CFk1T1PM-ncURvqYn7ZYqtBN06fDk9JCA-s130_provenance.
• NP345273.RANNJyBnia4x-Fw_2AEs9dxTe1hWP6NH4O25xM5LiToRw130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345273.RANNJyBnia4x-Fw_2AEs9dxTe1hWP6NH4O25xM5LiToRw130_provenance.
• NP345274.RAnQZ-oZWbvZTqAeXLBhe11yw48FOzh-RMd8-rZPO58s4130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345274.RAnQZ-oZWbvZTqAeXLBhe11yw48FOzh-RMd8-rZPO58s4130_provenance.